$9.37
4.58%
Nasdaq, Nov 06, 03:59 pm EST. Closed.
ISIN
US6838272085
Symbol
OCC

Optical Cable Corporation Stock News

Positive
●
Proactive Investors
●
17 days ago
Orthocell Ltd (ASX:OCC, OTC:ORHHF) closed the September quarter with revenue of A$3.6 million and continued growth in sales of its flagship nerve repair product, Remplir, supported by accelerating US adoption and expansion into new international markets. US Remplir unit sales rose 25% quarter-on-quarter to 149 units, driving a 20% increase in global Remplir revenue, which now accounts for more ...
Neutral
●
Proactive Investors
●
19 days ago
Regenerative medicine company Orthocell Ltd (ASX:OCC, OTC:ORHHF) will host an investor webinar on Thursday, October 22, 2026, providing an update on its September quarter results, the US rollout of Remplir and other strategic initiatives. The webinar will follow the release of Orthocell's quarterly results for the period ended September 30, 2026, and will give investors an overview of the compa...
Positive
●
Proactive Investors
●
26 days ago
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has reported encouraging early clinical results for its Remplir™ nerve repair technology in prostate cancer surgery, with 80% of patients demonstrating positive urinary continence outcomes and 75% of eligible patients showing a return of erectile function. The findings from an initial five-patient case series involving advanced prostate cancer patients support...
Neutral
●
Business Wire
●
about one month ago
CHICAGO--(BUSINESS WIRE)--OCC today announced it will provide CCP and settlement services for IEX Options LLC, a new options exchange from Investors' Exchange LLC.
Neutral
●
Business Wire
●
about one month ago
CHICAGO--(BUSINESS WIRE)--OCC today announced the launch of an AI-powered security investigation agent built with Amazon Web Services' Amazon Bedrock.
Positive
●
Proactive Investors
●
about 2 months ago
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has recorded the first commercial sales of its Remplir™ nerve repair product in Thailand, extending the regenerative medicine company's Asian footprint and opening another revenue-generating market for the product. The first sales follow Thai FDA approval and the appointment of MediTime as Orthocell's exclusive in-country distributor, giving the company an est...
Neutral
●
Business Wire
●
about 2 months ago
CHICAGO--(BUSINESS WIRE)--OCC today announced it will provide central counterparty clearing and settlement services for MX2 Options, a new options exchange from MEMX Group.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today